J07BX01 - Smallpox and Monkeypox Vaccines |
Propably not porphyrinogenic |
PNP |
Rationale
Based on the pharmacokinetics of the smallpox and mpox vaccine, no porphyrinogenic effects are expected.
Chemical description
Live attenuated virus vaccine.
Therapeutic characteristics
Indicated for protection against smallpox, mpox and disease caused by the vaccinia virus. It is administered by a subcutaneous injection.
Metabolism and pharmacokinetics
Vaccines are not metabolized by the cytochrome P450 system.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Government bodies | |
| 1. | European Medicines Agency (EMA). SmPC Imvanex.
|
|
| 2. | Norwegian institute of public health. Vaccines and vaccination.
|
|
Tradenames
Imvanex 
Imvanex vaccine · Jynneos vaccine · Smallpox Vaccine 
Imvanex 
Imvanex · Jynneos 
Qdenga 
Imvanex 
Imvanex 
Vaccines